R2032277 |
SR9243 |
SR9243 is a liver-X-receptor (LXR) inverse agonist that induces LXR-corepressor
|
R2032278 |
AM-095 |
AM095 (free acid) is a potent LPA1 receptor antagonist with IC50 values of 0.98
|
R2032279 |
NPS2143;NPS-2143(SB-262470A) |
NPS-2143 (SB-262470A), an orally active calcilytic agent, is a selective and pot
|
R2032280 |
Taselisib(GDC-0032) |
Taselisib (GDC-0032) is a potent PI3K inhibitor targets PIK3CA mutations, with K
|
R2032281 |
TAK-285 |
TAK-285 is a potent, selective, ATP-competitive and orally active HER2 and EGFR(
|
R2032282 |
SC1(Pluripotin) |
Pluripotin is a dual inhibitor of ERK1 and RasGAP with KDs of 98 nM and 212 nM,
|
R2032283 |
AZD8186 |
AZD8186 is a PI3K inhibitor, which potently inhibits PI3Kβ (IC50=4 nM) and PI3Kδ
|
R2032284 |
SRT3109 |
SRT3109 is an antagonist of CXCR2, with a pIC50 of 8.2, and used in the research
|
R2032285 |
TG101209 |
TG101209 is a selective JAK2 inhibitor with IC50 of 6 nM, less potent to Flt3 an
|
R2032286 |
CC-223 |
CC-223 is a potent, selective, and orally bioavailable inhibitor of mTOR kinase,
|
R2032287 |
Bexagliflozin;EGT1442;EGT0001442;THR-1442 |
Bexagliflozin is a potent and selective SGLT2 inhibitor with IC50 value of 5.6 μ
|
R2032288 |
MK-886 (L 663536) |
MK-886 (L 663536) is a potent, cell-permeable and orally active FLAP (IC50 of 30
|
R2032289 |
ABT639;ABT-639 |
ABT-639 is a novel, peripherally acting, selective T-type Ca2+ channel blocker.
|
R2032290 |
CHIR-090;CHIR090 |
CHIR-090 is a potent, slow, tight-binding inhibitor of the LpxC deacetylase.It b
|
R2032291 |
FLT3-IN-2 |
FLT3-IN-2 is a FLT3 inhibitor with IC50 of < 1 μM, detailed information refer to
|
R2032292 |
GDC0084 |
GDC-0084 is a brain penetrant inhibitor of PI3K and mTOR, with Kis of 2 nM, 46 n
|
R2032293 |
AC710 |
AC710 is a potent PDGFR inhibitor with Kds of 0.6, 1.57, 1, 1.3, 1.0 nM for FLT3
|
R2032294 |
P7C3-A20 |
P7C3-A20 is a derivative of P7C3 with potent neuroprotective activity.
|
R2032295 |
NSC23766;NSC-23766 |
NSC 23766 is a specific inhibitor of the binding and activation of Rac GTPase, u
|
R2032296 |
GSK484 hydrochloride(GTPL8577) |
GSK484 hydrochloride (GTPL8577) is a selective and reversible peptidylarginine d
|
R2032297 |
GDC-0810;Lifirafenib(BGB-283) |
Lifirafenib (BGB-283) is a novel and potent Raf Kinase and EGFR inhibitor with I
|
R2032298 |
A 769662 |
A-769662 is a potent, reversible AMPK activator with EC50 of 0.8 μM.
|
R2032299 |
MT-1303;Amiselimod |
Amiselimod is a novel sphingosine 1-phosphate receptor-1 (S1P1) modulator, desig
|
R2032301 |
SB415286 |
SB 415286 is a potent and selective cell permeable inhibitor of GSK-3α, with an
|
R2032302 |
Tomivosertib(eFT508) |
Tomivosertib (eFT508) is a potent, highly selective, and orally bioavailable MNK
|